Bond.az White LogoBond.az Black Logo

Aletheia Capital Reaffirms Circle Stock Rating

Aletheia Capital reaffirms Buy rating on Circle Internet Group amid U.S. stablecoin regulatory advantages. Stock at $111.39.

Jack Scott
ByJack Scott- Senior Editor
|
0

Bond.az - Aletheia Capital has reaffirmed a Buy rating on Circle Internet Group (NYSE:CRCL), citing its competitive edge amid evolving U.S. stablecoin regulations. The stock trades at $111.39, down 10% over the past week but up 60% over six months.

The firm notes that current regulations favor established institutional players like Circle while raising barriers for new entrants. Banking regulators are tightening compliance standards as formal legislation stalls.

The Clarity Act, key for federal stablecoin rules, faces procedural gridlock due to midterm election volatility. Aletheia expects passage in the first half of 2027.

FDIC's Post-Quantum Cryptography Request has raised entry barriers, benefiting incumbents. Circle's USYC has become a premier tokenized liquidity vehicle.

Despite no profit in the past year, analysts predict profitability this year, driven by 51% revenue growth. Circle holds more cash than debt.

Recent news: Shareholders approved directors at the annual meeting. H.C. Wainwright upgraded to Buy, citing ARC token presale. Needham raised price target to $150. Baird reiterated Outperform with $138 target.

More News
Today / 10:31
|
290

Wolfe Research Initiates CytomX Stock with Outperform

Wolfe Research initiated CytomX Therapeutics (CTMX) with an outperform rating and $3.50 target. Varseta-M shows promise in colorectal cancer.

0
Today / 10:30
|
842

Wolfe Research initiates Mirum with outperform

Wolfe Research starts Mirum Pharmaceuticals with outperform rating and $145 price target, citing strong pipeline potential.

0
Today / 10:14
|
236

Wolfe Research Initiates Oklo with Peerperform

Wolfe Research initiated Oklo Inc. with a Peerperform rating. Learn about the company's targets, finances, and stock performance.

0
Today / 09:31
|
784

Jefferies Initiates X-Energy Stock with Hold Rating

Jefferies initiates X-Energy stock coverage with a Hold rating and $28 target. Learn about risks and recent performance.

0
Today / 09:11
|
441

UBS Upgrades Jazz Pharma on Ziihera Potential

UBS upgrades Jazz Pharmaceuticals to Buy with a $307 target on Ziihera potential. Bond.az provides detailed analysis and stock insights.

0
Today / 09:10
|
408

UBS Starts X-Energy Stock Coverage with Buy

UBS starts coverage on X-Energy stock with a buy rating and $40 target. The company's reactor model and growth potential are highlighted.

0
Today / 08:55
|
525

Goldman Sachs Upgrades Brambles on Subcontractor Exit

Goldman Sachs upgrades Brambles to Neutral after subcontractor exit. Stock drops 17%, but Bond.az analysis suggests undervaluation with $32.76 Fair Value.

0
Yesterday / 20:21
|
381

RBC Capital hikes Dominion Resources price target

RBC Capital raises Dominion price target to $72 on NextEra deal. Sector Perform rating maintained with 7% arbitrage spread.

0
Yesterday / 20:20
|
884

BofA raises Candel price target to $9

BofA raises Candel price target to $9 after 39% improvement in prostate cancer survival data.

0
Yesterday / 18:11
|
808

Roblox rebounds on user growth, Needham says

Needham reiterates Roblox Buy rating amid user growth rebound. Stock has 27% upside to $60 target.

0
Yesterday / 17:51
|
287

US Tiger Securities Boosts Baidu Price Target on AI

US Tiger Securities raised Baidu price target to $160 on AI growth. AI revenue now exceeds half of business.

0
Yesterday / 15:50
|
224

AMAT and LRCX stocks defended by Lynx

Lynx Equity defends AMAT and LRCX stocks with bullish price targets of $540 and $325 respectively.

0
...